Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials

BACKGROUND: Many patients with obsessive-compulsive disorder do not respond adequately to serotonin reuptake inhibitors. Augmentation with antipsychotic drugs can be beneficial in this regard. However, since new relevant randomized controlled trials evaluating new antipsychotics were conducted, a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Dold, Markus, Aigner, Martin, Lanzenberger, Rupert, Kasper, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576518/
https://www.ncbi.nlm.nih.gov/pubmed/25939614
http://dx.doi.org/10.1093/ijnp/pyv047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576518/
https://www.ncbi.nlm.nih.gov/pubmed/25939614
http://dx.doi.org/10.1093/ijnp/pyv047

Ejemplares similares